DE2047317C3 - Verfahren zur Herstellung einer Protease mit der Bezeichnung AM-Protease aus dem Pilz Armiüaria mellea, diese Protease selbst und sie enthaltende pharmazeutische Stoffzusammensetzungen - Google Patents

Verfahren zur Herstellung einer Protease mit der Bezeichnung AM-Protease aus dem Pilz Armiüaria mellea, diese Protease selbst und sie enthaltende pharmazeutische Stoffzusammensetzungen

Info

Publication number
DE2047317C3
DE2047317C3 DE2047317A DE2047317A DE2047317C3 DE 2047317 C3 DE2047317 C3 DE 2047317C3 DE 2047317 A DE2047317 A DE 2047317A DE 2047317 A DE2047317 A DE 2047317A DE 2047317 C3 DE2047317 C3 DE 2047317C3
Authority
DE
Germany
Prior art keywords
protease
water
solution
mellea
mycelium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2047317A
Other languages
German (de)
English (en)
Other versions
DE2047317B2 (de
DE2047317A1 (de
Inventor
Douglas Alderley Edge Broadbent
Ralph William Cheadle Turner
Peter Leslie Knutsford Walton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB22129/70A external-priority patent/GB1263956A/en
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of DE2047317A1 publication Critical patent/DE2047317A1/de
Publication of DE2047317B2 publication Critical patent/DE2047317B2/de
Application granted granted Critical
Publication of DE2047317C3 publication Critical patent/DE2047317C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification
    • Y10S435/815—Enzyme separation or purification by sorption
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
DE2047317A 1969-09-26 1970-09-25 Verfahren zur Herstellung einer Protease mit der Bezeichnung AM-Protease aus dem Pilz Armiüaria mellea, diese Protease selbst und sie enthaltende pharmazeutische Stoffzusammensetzungen Expired DE2047317C3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB4755469 1969-09-26
GB22129/70A GB1263956A (en) 1969-09-26 1969-09-26 Enzymes

Publications (3)

Publication Number Publication Date
DE2047317A1 DE2047317A1 (de) 1971-04-15
DE2047317B2 DE2047317B2 (de) 1979-08-02
DE2047317C3 true DE2047317C3 (de) 1980-04-03

Family

ID=26255751

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2047317A Expired DE2047317C3 (de) 1969-09-26 1970-09-25 Verfahren zur Herstellung einer Protease mit der Bezeichnung AM-Protease aus dem Pilz Armiüaria mellea, diese Protease selbst und sie enthaltende pharmazeutische Stoffzusammensetzungen

Country Status (12)

Country Link
US (1) US3713981A (enExample)
JP (1) JPS529757B1 (enExample)
BE (1) BE756369A (enExample)
CA (1) CA921848A (enExample)
CH (1) CH575963A5 (enExample)
DE (1) DE2047317C3 (enExample)
DK (1) DK127189B (enExample)
ES (1) ES384010A1 (enExample)
FR (1) FR2070093B1 (enExample)
IE (1) IE34463B1 (enExample)
NL (1) NL169499C (enExample)
SE (1) SE391931B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4039658A (en) * 1972-04-05 1977-08-02 John Burnham King Fibrinolytic substances
US4086140A (en) * 1972-04-05 1978-04-25 John Burnham King Process for isolating fibrinolytic substances
MY130475A (en) * 2000-08-25 2007-06-29 Contura As Polyacrylamide hydrogel and its use as an endoprosthesis
US6630139B2 (en) * 2001-08-24 2003-10-07 Academia Sinica Fibrinogenolytic proteases with thrombolytic and antihypertensive activities: medical application and novel process of expression and production
CN101221153B (zh) * 2007-10-15 2011-05-18 东北师范大学遗传与细胞研究所 蜜环菌液体发酵产物hplc指纹图谱的建立方法
DE102013204081A1 (de) * 2013-03-11 2014-09-11 Beiersdorf Ag Wirkstoffkombinationen aus Alkylamidothiazolen und einen oder mehreren kosmetisch oder dermatologisch unbedenklichen Konservierungsmitteln

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3256157A (en) * 1959-02-20 1966-06-14 Astra Pharma Prod Agents having a fibrinolytic activity and being derived from molds and a process of making and using same

Also Published As

Publication number Publication date
NL169499C (nl) 1982-07-16
DE2047317B2 (de) 1979-08-02
ES384010A1 (es) 1973-05-01
FR2070093B1 (enExample) 1974-06-21
CH575963A5 (enExample) 1976-05-31
US3713981A (en) 1973-01-30
NL169499B (nl) 1982-02-16
IE34463L (en) 1971-03-26
JPS529757B1 (enExample) 1977-03-18
IE34463B1 (en) 1975-05-14
NL7013461A (enExample) 1971-03-30
DK127189B (da) 1973-10-01
DE2047317A1 (de) 1971-04-15
CA921848A (en) 1973-02-27
FR2070093A1 (enExample) 1971-09-10
BE756369A (fr) 1971-03-18
SE391931B (sv) 1977-03-07

Similar Documents

Publication Publication Date Title
EP0209061B1 (de) Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel
EP0181465B1 (de) Blutgerinnungshemmende Proteine, Verfahren zur Herstellung sowie deren Verwendung
EP0207956B1 (de) Hirudin-pa und dessen derivate, verfahren zu deren herstellung und deren verwendung
DE3617752C2 (enExample)
Gopalakrishnakone et al. Sites of action of Mojave toxin isolated from the venom of the Mojave rattlesnake
EP0480906B1 (de) Pharmazeutische Zubereitung auf Basis von Lys-Plasminogen
DE68929388T2 (de) Aus Harn isolierte antikoagulierende Verbindung
DE2734821A1 (de) Verfahren zur herstellung einer blutgerinnungsfoerdernden praeparation aus menschlichem blutplasma
DE3886175T2 (de) Trigramin, ein Polypeptid, das die Aggregation der Blutplättchen hemmt.
CH664495A5 (de) Pharmazeutische formulierung.
DE3150318C2 (de) "Verfahren zur Herstellung eines Polysaccharidderivats des Fibrinolysins"
EP0271885B1 (de) Arzneimittel enthaltend das Gewebeprotein PP4, Verfahren zur Herstellung von PP4 und zu seiner Pasteurisierung sowie die Verwendung von PP4
DE3718889A1 (de) Verfahren zur herstellung einer loesung hoher spezifischer volumenaktivitaet von einem protein mit gewebe-plasminogenaktivator (t-pa)-aktivitaet, loesung, enthaltend protein mit t-pa-aktivitaet und verwendung der loesung in der human- und veterinaermedizin
DE2047317C3 (de) Verfahren zur Herstellung einer Protease mit der Bezeichnung AM-Protease aus dem Pilz Armiüaria mellea, diese Protease selbst und sie enthaltende pharmazeutische Stoffzusammensetzungen
EP0101063A2 (de) Neues Polypeptid mit Wirkung auf das Immunsystem, Verfahren zu seiner Isolierung und Reinigung, seine Verwendung und dieses enthaltende Mittel
DE3119157A1 (de) Verfahren zur herstellung von und danach hergestelltes plasminogen
DE69126437T2 (de) Inhibitor der blutplättchen-aggregation
DE3306944C2 (enExample)
DE3689927T2 (de) Reagens und Verfahren.
DE3586952T2 (de) Fibrinophiler urokinase-komplex und dessen herstellung.
DE1442134B2 (de) In vivo antikoagulierend wirkendes und defibrinierendes Enzym
DE3390272C2 (de) Plasminogen-Aktivator, Verfahren zu seiner Herstellung und denselben enthaltendes thrombolytisches Mittel
DE1617279C3 (de) Verfahren zur Herstellung eines die Aspergillopeptidase ARL 1 enthaltenden Präparates aus Aspergillus oryzae und sie enthaltendes Arzneimittel
DE69127757T2 (de) Thrombolytisches peptid, seine produktion und thrombolisches agens
EP0189485A1 (de) Hexapeptid

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee